PMC:7463108 / 104948-105188
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T37 | 55-64 | Body_part | denotes | G protein | http://purl.org/sig/ont/fma/fma61788 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T86579 | 21-28 | Chemical | denotes | ligands | http://purl.obolibrary.org/obo/CHEBI_52214 |
| T61999 | 57-64 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3560 | 97-109 | Gene | denotes | β-arrestin 2 | Gene:409 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1320 | 0-240 | Sentence | denotes | It is suggested that ligands that display bias towards G protein-mediated pathways and away from β-arrestin 2 recruitment may have improved therapeutic profiles against the development of tolerance and dependence/addiction (McPherson et al. |